We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Molina (MOH) Q1: Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Molina (MOH - Free Report) to post quarterly earnings of $5.86 per share in its upcoming report, which indicates a year-over-year increase of 2.3%. Revenues are expected to be $11.12 billion, up 12% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Molina metrics that Wall Street analysts commonly model and monitor.
Based on the collective assessment of analysts, 'Revenue- Premium tax revenue' should arrive at $327.98 million. The estimate indicates a year-over-year change of +10.4%.
Analysts predict that the 'Revenue- Premium revenue' will reach $10.61 billion. The estimate indicates a change of +11.6% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Investment income' will reach $102.05 million. The estimate suggests a change of -5.5% year over year.
The consensus estimate for 'Revenue- Other revenue' stands at $22.37 million. The estimate indicates a year-over-year change of +1.7%.
The combined assessment of analysts suggests that 'MCR - Total' will likely reach 88.5%. Compared to the present estimate, the company reported 88.5% in the same quarter last year.
Analysts forecast 'MCR - Medicare' to reach 83.4%. Compared to the current estimate, the company reported 88.7% in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'MCR - Marketplace' of 76.5%. The estimate compares to the year-ago value of 73.3%.
Analysts' assessment points toward 'Ending Membership by Program - Total' reaching 5.95 million. The estimate is in contrast to the year-ago figure of 5.73 million.
The average prediction of analysts places 'Ending Membership by Program - Medicaid' at 5.1 million. The estimate compares to the year-ago value of 5.12 million.
Analysts expect 'Ending Membership by Program - Medicare' to come in at 267.02 thousand. The estimate is in contrast to the year-ago figure of 258 thousand.
It is projected by analysts that the 'Ending Membership by Program - Marketplaces' will reach 583.43 thousand. The estimate is in contrast to the year-ago figure of 346 thousand.
According to the collective judgment of analysts, 'MCR - Medicaid' should come in at 90.9%. The estimate compares to the year-ago value of 89.7%.
Shares of Molina have experienced a change of +4% in the past month compared to the -5.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), MOH is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into Molina (MOH) Q1: Wall Street Projections for Key Metrics
Wall Street analysts expect Molina (MOH - Free Report) to post quarterly earnings of $5.86 per share in its upcoming report, which indicates a year-over-year increase of 2.3%. Revenues are expected to be $11.12 billion, up 12% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Molina metrics that Wall Street analysts commonly model and monitor.
Based on the collective assessment of analysts, 'Revenue- Premium tax revenue' should arrive at $327.98 million. The estimate indicates a year-over-year change of +10.4%.
Analysts predict that the 'Revenue- Premium revenue' will reach $10.61 billion. The estimate indicates a change of +11.6% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Investment income' will reach $102.05 million. The estimate suggests a change of -5.5% year over year.
The consensus estimate for 'Revenue- Other revenue' stands at $22.37 million. The estimate indicates a year-over-year change of +1.7%.
The combined assessment of analysts suggests that 'MCR - Total' will likely reach 88.5%. Compared to the present estimate, the company reported 88.5% in the same quarter last year.
Analysts forecast 'MCR - Medicare' to reach 83.4%. Compared to the current estimate, the company reported 88.7% in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'MCR - Marketplace' of 76.5%. The estimate compares to the year-ago value of 73.3%.
Analysts' assessment points toward 'Ending Membership by Program - Total' reaching 5.95 million. The estimate is in contrast to the year-ago figure of 5.73 million.
The average prediction of analysts places 'Ending Membership by Program - Medicaid' at 5.1 million. The estimate compares to the year-ago value of 5.12 million.
Analysts expect 'Ending Membership by Program - Medicare' to come in at 267.02 thousand. The estimate is in contrast to the year-ago figure of 258 thousand.
It is projected by analysts that the 'Ending Membership by Program - Marketplaces' will reach 583.43 thousand. The estimate is in contrast to the year-ago figure of 346 thousand.
According to the collective judgment of analysts, 'MCR - Medicaid' should come in at 90.9%. The estimate compares to the year-ago value of 89.7%.
View all Key Company Metrics for Molina here>>>
Shares of Molina have experienced a change of +4% in the past month compared to the -5.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), MOH is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>